title: New directions in the prediction of pre-eclampsia.
abstract: Pre-eclampsia remains an important worldwide cause of maternal and perinatal morbidity and mortality. Improved prediction of those destined to develop this condition would allow for timely initiation of prophylactic therapy, appropriate antenatal surveillance and better targeted research into preventive interventions. This paper reviews recent research into strategies for the prediction of pre-eclampsia, including the use of maternal risk factors, mean maternal arterial pressure, ultrasound parameters and biomarkers. The most promising strategies involve multiparametric approaches, which use a variety of individual parameters in combination, as has been established in first-trimester aneuploidy screening. The paper concludes with a discussion of the issues around the introduction of such testing into clinical practice.
authors.affiliation: Department of Perinatal Medicine, The Royal Women's Hospital, Parkville, Victoria, Australia.
authors.forename: Stefan C
authors.initials: SC
authors.lastname: Kane
authors.forename: Fabricio
authors.initials: F
authors.lastname: Da Silva Costa
authors.forename: Shaun P
authors.initials: SP
authors.lastname: Brennecke
mesh_terms: D001241:Aspirin / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D002118:Calcium / Q000627:therapeutic use; D005260:Female; D006801:Humans; D011225:Pre-Eclampsia / Q000175:diagnosis* / Q000517:prevention & control; D011247:Pregnancy; D012307:Risk Factors; D016216:Ultrasonography, Prenatal; D055988:Uterine Artery / Q000000981:diagnostic imaging
chemical_list: D015415:Biomarkers; D001241:Aspirin; D002118:Calcium
keywords: aspirin; blood pressure; mass screening; pre-eclampsia; pregnancy-induced hypertension